201 Users Online
Metagenomics Market Segmented Sequencing and Bioinformatics in Technology and Instrument & Software and Consumable, Reagents, Consumables, Instruments by Product and Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, and Agriculture, Diagnostic, Soil Microbiome in Application
The metagenomics market is dominated by the leading players, for example, GE Healthcare, Thermo Fischer Scientific, Inc., Danaher and Merck KGaA. These companies are focusing on to launch new products in the metagenomics market. The companies operating in the metagenomics market are focusing on mergers and acquisitions to expand their portfolio. To expand in the metagenomics market, the companies are working together. In this market, the companies are focusing on to expand their distribution channels in the emerging countries. Apart from this, many companies are planning to invest in new facilities to increase the production capacity.
There is an increase in the awareness regarding genetic disorders, which is expected to boost the growth of the metagenomics market. Clinical diagnostics is the most important application area, where metagenomics plays an important role. For example, in India, the occurrence of genetic disorders has increased. The American region is expected to hold large share of the global metagenomics sequencing market owing to the rising genetic abnormalities and diseases, governmental support for the research and development in genetics, and presence of sophisticated infrastructure.
With technological advancements, many new bioinformatics tools have been introduced in the metagenomics market, which increase the revenue in the metagenomics market. The improved genomic tools and advanced technological platforms are the key factors driving the growth of the global metagenomic market.
With the development of new research laboratories, there is an increase in research and developmental activities which is driving the metagenomics market Introduction of microarray which is the fast-growing segment in diagnostics has led to an increase in the revenue share of the metagenomics market. The evolution of microarrays by different companies manufacturing metagenomics products have increased the diagnosis rate of genetic disorders.
Factors such as use of advanced bioinformatics tools, high throughput screening methods and development of cost-effective methods are expected to drive the growth of the metagenomics market.
Metagenomics plays an important role in bioremediation as microorganisms are the main agents of bioremediation. Microorganisms are responsible for degradation of environmental pollutants. The metagenome of a contaminated environment includes all the DNA involved in that environment. Genetic information is used to understand how contaminants and treatments are affecting the complex microbial communities that exist in the environment.
Apart from environmental toxicology, development of new research laboratories is playing an important role in the growth of the metagenomics market. With technological advancements, many new bioinformatics tools have been introduced in the market, which is expected to contribute to the growth of the metagenomics market. Besides, advanced technological platforms and improved genomic tools are the key factors expected to drive the growth of the global metagenomics market.
The companies are focusing on to develop new types of sequencing products that aim at increasing the product portfolio and revenue of the metagenomics market. New sequencing techniques have been introduced which are expected to increase the revenue of metagenomics market.
Advancement in bioinformatics programming has enabled researchers to conduct 3D metagenomics experiments with the help of new bioinformatic tools. For instance, in February 2017, a team of researchers at the Institute Pasteur conducted an experiment using 3D structures of DNA fragments collected from microbiota of mouse intestine to analyze interactions between phage and bacteria.
Introduction of various new genome projects allow the researchers to make a new database for various research and developmental activities. Development of other genomic programs are also expected to increase the revenue of the metagenomics market. Many western countries are developing their own programs in the metagenomics market. For example, Australia is currently working on a four year 100000 genome project, which will sequence the patients with rare diseases and cancer.
The competition section of the report features profiles of the key players operating in the market based on their market shares, differential strategies, product offerings, marketing approach and company dashboard. Examples of some of the key players featured in this report include Illumina Inc, Thermo Fisher Scientific, Trivitron Healthcare, Qiagen, Symbio Scientific Pvt Ltd., Infobio, Bio-Rad laboratories, Merck KgaA, Promega Corporation, and Perkin Elmer Inc.
Thermo Fisher Scientific and Qiagen offer a range of products for metagenomics, which include various DNA extraction kits and others. Merck KgaA is involved in manufacturing of DNA polymerases, which play a major role in DNA fragments sequencing.
The key manufacturers of metagenomics are focusing on developing new sequencing kits. The companies are focusing on to expand their presence in the emerging markets such as South America and Eastern Europe. They are mainly involved in mergers to grow in the metagenomics market. For example, in 2017, Qiagen and NeuMoDx announced strategic partnership to offer next generation systems for fully integrated diagnostic testing.
Request Information on the Metagenomics Market Competitive Landscape
Metagenomics is a new high throughput screening tool for the microbial community. It basically refers to the study of genetic material recovered from the microbial community present in the environmental sample.
The primary aim of conducting a metagenomics experiment is the analysis of genes and the study of metabolic pathways. Metagenomics is used to explore new pharmaceutical and industrial products from the environment. It deals with the study of composition and taxonomy of microbial culture. The metagenomics market deals with three kind of products – library preparation kits, sample extraction kits and metagenomic sequencing kits. The total genome is isolated from the environment, fragmented and then sequenced.
FMI conducted a research study on metagenomics market for the forecast period 2018 to 2028. The metagenomics market report offers a comprehensive evaluation of the business opportunities prevailing in the metagenomics market along with insights on the metagenomics current trend, disease incidences, and awareness level for genetic disorders and market competition. The report elaborates the macroeconomic factors influencing the dynamics of metagenomics market and its futuristic potential.
The report offers a comprehensive taxonomy of metagenomics market based on product type, applications, end users and region. There are three types of kits which are majorly used in the metagenomics market. These kits are library preparation kits, sample extraction kits and metagenomics sequencing kits. The library preparation kits involve the preparation of nucleic acids targets using a series of enzymatic reactions. The sample extraction kits are used to isolate the genomic DNA from a wide range of samples such as cells and tissues. Metagenomic sequencing kits are used to sequence the DNA fragments.
There are various applications of metagenomics including microbial diversity, bioremediation, bio surfactants and antibiotics production, clinical diagnostics. Clinical diagnostics is expected to hold large share in the metagenomics market. End-use segments in metagenomics market include pharmaceutical industries, hospitals, academic and research institutes, research laboratories and others, such as clinics, emergency services. The metagenomics market has been analysed across regions, namely North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan and MEA.
Some of the additional questions addressed in this report on the metagenomics market-
The metagenomics market has been estimated based on supply-demand approach. A triangulation methodology is adopted to derive the market size, which is primarily based on overall expenditure on life science research funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, applications, technologies and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level.
This methodology ensures accuracy and high quality of information. This information is further validated with rigorous primary research (including interviews, , in-person interactions, surveys and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). With this approach, the report on metagenomics market projects the industry attractiveness of every major segment over the forecast period.